Navigation Links
MicroConstants China Signs Site Management Organization Agreement with the Clinical Research Center of No. 307 Hospital
Date:1/28/2013

BEIJING, Jan. 28, 2013 /PRNewswire/ -- MicroConstants China Inc., a Contract Research Organization (CRO) conducting preclinical pharmacokinetic studies, early-stage clinical trials, and regulated bioanalysis in China, has signed a strategic collaboration agreement with the clinical research center of the No. 307 Hospital of People's Liberation Army to provide site management services. The agreement designates MicroConstants China as No. 307 Hospital's official site management organization (SMO).

Over the past three years, MicroConstants China has worked closely with the Phase I unit of No. 307 Hospital to implement quality systems and procedures that comply with International Conference on Harmonization Good Clinical Practice (ICH GCP) guidelines. This has included developing standard operating procedures (SOP), training clinical site personnel, performing quality assurance (QA) audits, installing a clinical trial information management system (CTIMS), and obtaining SIDCER Recognition from the Forum for Ethical Review Committees in the Asian and Western Pacific Region (FERCAP).

"Through our collaboration with MicroConstants China, we have learned the true meaning of GCP compliance in daily practice and are now capable of identifying deficiencies and coming up with corrective actions to address them," said Dr. Zeyuan Liu , director of the clinical pharmacology unit at No. 307 Hospital. "Working with MicroConstants China enabled us to improve our quality system in a short period of time and effectively win contracts from major global pharmaceutical companies."

"The execution of this strategic collaboration agreement verifies our achievements and is an important step for our SMO business," said Dr. Q. David Yang , chief executive officer of MicroConstants China. "Our goal is to implement ICH GCP compliant quality systems for more clinical trial centers in China so their clinical trial data can be submitted directly to the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for approval."

About the No. 307 Hospital Clinical Research Center
Established in 1957, the No. 307 Hospital of People's Liberation Army is among the top tier hospitals in China with 38 specialty groups and over 1,100 beds. Their clinical trial center is certified by the SFDA for Phase I clinical studies and Phase II/III/IV clinical studies for cancer, hematology, anti-radiation, detoxification, and anti-dependency drugs. The clinical research center has conducted clinical trials for more than 200 sponsors, including eight of the top ten global pharmaceutical companies.

About MicroConstants China Inc.
MicroConstants China Inc. is a Contract Research Organization (CRO) that was established in 2007 by the founder and president of MicroConstants, Inc., a bioanalytical and DMPK specialty CRO in San Diego, California with over a decade of GLP compliance history. Located in Beijing, MicroConstants China conducts preclinical and clinical pharmacokinetic studies, provides regulated bioanalysis and analytical services, and offers early-stage clinical trial management services and quality system consulting. For more information, please visit http://www.microconstants.com.cn.


'/>"/>
SOURCE MicroConstants China Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Botanic Appoints Jack Zhao as Independent Director
2. Dental Radiology Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
3. Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
4. Respiratory Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
5. The 1st China International Dental CAD/CAM Forum to Be Held in DenTech China 2013
6. Perceptive Informatics Opens First Customer Care Office in China
7. Affluence, an Aging Population, and Anticipated Rx-to-OTC Switches Boost a Healthy $32 Billion OTC Market in China, According to Kline
8. Government Investments in Upgrades Sustain Laboratory Analytical Instrumentation Market in China, Finds Frost & Sullivan
9. Medical Device Market Updates: IVD and Ophthalmic Devices Dominate Chinas $30.5 bn Medical Device Market; Invisible Hearing Aids Set to Make Big Noise
10. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
11. DenTech China 2012 Closed with Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at www.diabetesscholars.org by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Volumes: Global Analysis (United States, China, Japan, Brazil, United ... to their offering. ... healthcare business planners, provides surgical procedure volume data in ... with an in-depth analysis of growth drivers and inhibitors, ...
Breaking Medicine Technology:
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
Breaking Medicine News(10 mins):